Nesen A, Savicheva K, Semenovykh P, Galchiskaya V. Vasopressin marker copeptin and the development of renal and metabolic disorders in patients with type 2 diabetes. Ukr. J. Nephrol. Dial. [Internet]. 2022Jun.19 [cited 2026Jul.23];0(3(75):55-2. Available from: https://ukrjnd.com.ua/index.php/journal/article/view/646